Immunocore Holdings plc (IMCR)
 NASDAQ: IMCR · Real-Time Price · USD
 32.92
 +0.73 (2.27%)
  At close: Oct 31, 2025, 4:00 PM EDT
33.09
 +0.17 (0.52%)
  After-hours: Oct 31, 2025, 4:10 PM EDT
Immunocore Holdings Revenue
Immunocore Holdings had revenue of $97.96M in the quarter ending June 30, 2025, with 29.93% growth. This brings the company's revenue in the last twelve months to $356.15M, up 26.78% year-over-year. In the year 2024, Immunocore Holdings had annual revenue of $310.20M with 24.37% growth.
Revenue (ttm) 
 $356.15M
Revenue Growth 
 +26.78%
P/S Ratio 
 4.66
Revenue / Employee 
 $722,404
Employees 
 493
Market Cap 
1.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 310.20M | 60.77M | 24.37% | 
| Dec 31, 2023 | 249.43M | 75.07M | 43.05% | 
| Dec 31, 2022 | 174.36M | 137.88M | 377.91% | 
| Dec 31, 2021 | 36.48M | -4.63M | -11.26% | 
| Dec 31, 2020 | 41.11M | 7.12M | 20.94% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| AbbVie | 59.64B | 
| Eli Lilly and Company | 59.42B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
IMCR News
- 7 weeks ago - Immunocore Holdings Plc (IMCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 2 months ago - Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Immunocore reports second quarter financial results and provides a business update - GlobeNewsWire
- 3 months ago - Immunocore to report second quarter 2025 financial results and host call on August 7, 2025 - GlobeNewsWire
- 4 months ago - Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions - GlobeNewsWire
- 5 months ago - Immunocore to present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Immunocore reports first quarter financial results and provides a business update - GlobeNewsWire